Literature DB >> 16650608

Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.

J P Q Zhu1, W Xu, J A Angulo.   

Abstract

Methamphetamine (METH) is an illicit and potent psychostimulant, which acts as an indirect dopamine agonist. In the striatum, METH has been shown to cause long lasting neurotoxic damage to dopaminergic nerve terminals and recently, the degeneration and death of striatal cells. The present study was undertaken to identify the type of striatal neurons that undergo apoptosis after METH. Male mice received a single high dose of METH (30 mg/kg, i.p.) and were killed 24 h later. To demonstrate that METH induces apoptosis in neurons, we combined terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining with immunohistofluorescence for the neuronal marker neuron-specific nuclear protein (NeuN). Staining for TUNEL and NeuN was colocalized throughout the striatum. METH induces apoptosis in approximately 25% of striatal neurons. Cell counts of TUNEL-positive neurons in the dorsomedial, ventromedial, dorsolateral and ventrolateral quadrants of the striatum did not reveal anatomical preference. The type of striatal neuron undergoing cell death was determined by combining TUNEL with immunohistofluorescence for selective markers of striatal neurons: dopamine- and cAMP-regulated phosphoprotein, of apparent Mr 32,000, parvalbumin, choline acetyltransferase and somatostatin (SST). METH induces apoptosis in approximately 21% of dopamine- and cAMP-regulated phosphoprotein, of apparent Mr 32,000-positive neurons (projection neurons), 45% of GABA-parvalbumin-positive neurons in the dorsal striatum, and 29% of cholinergic neurons in the dorsal-medial striatum. In contrast, the SST-positive interneurons were refractory to METH-induced apoptosis. Finally, the amount of cell loss determined with Nissl staining correlated with the amount of TUNEL staining in the striatum of METH-treated animals. In conclusion, some of the striatal projection neurons and the GABA-parvalbumin and cholinergic interneurons were removed by apoptosis in the aftermath of METH. This imbalance in the populations of striatal neurons may lead to functional abnormalities in the output and processing of neural information in this part of the brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650608      PMCID: PMC2882192          DOI: 10.1016/j.neuroscience.2006.02.055

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  83 in total

1.  Role of dopamine in the neurotoxic effects of methamphetamine.

Authors:  C J Schmidt; J K Ritter; P K Sonsalla; G R Hanson; J W Gibb
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

2.  Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.

Authors:  M F Beal; N W Kowall; D W Ellison; M F Mazurek; K J Swartz; J B Martin
Journal:  Nature       Date:  1986 May 8-14       Impact factor: 49.962

3.  Evidence for the preferential localization of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum.

Authors:  Q Chen; L Veenman; K Knopp; Z Yan; L Medina; W J Song; D J Surmeier; A Reiner
Journal:  Neuroscience       Date:  1998-04       Impact factor: 3.590

4.  Selective sparing of a class of striatal neurons in Huntington's disease.

Authors:  R J Ferrante; N W Kowall; M F Beal; E P Richardson; E D Bird; J B Martin
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

5.  Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase.

Authors:  C J Wilson; P M Groves
Journal:  J Comp Neurol       Date:  1980-12-01       Impact factor: 3.215

6.  Evidence for carrier-mediated efflux of dopamine from corpus striatum.

Authors:  N Y Liang; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1982-08-01       Impact factor: 5.858

7.  Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.

Authors:  N Y Liang; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

8.  A type of aspiny neuron in the rat neostriatum accumulates [3H]gamma-aminobutyric acid: combination of Golgi-staining, autoradiography, and electron microscopy.

Authors:  J P Bolam; D J Clarke; A D Smith; P Somogyi
Journal:  J Comp Neurol       Date:  1983-01-10       Impact factor: 3.215

9.  Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity.

Authors:  J W Gibb; F J Kogan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

10.  Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.

Authors:  A J Hotchkiss; J W Gibb
Journal:  J Pharmacol Exp Ther       Date:  1980-08       Impact factor: 4.030

View more
  62 in total

1.  Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice.

Authors:  Jing Wang; Jesus A Angulo
Journal:  Brain Res       Date:  2010-11-11       Impact factor: 3.252

Review 2.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

3.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

4.  Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.

Authors:  Eun-Joo Shin; Seung Woo Shin; Thuy-Ty Lan Nguyen; Dae Hun Park; Myung-Bok Wie; Choon-Gon Jang; Seung-Yeol Nah; Byung Wook Yang; Sung Kwon Ko; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2014-01-16       Impact factor: 5.590

5.  PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine.

Authors:  Joanna S Fowler; Carsten Kroll; Richard Ferrieri; David Alexoff; Jean Logan; Stephen L Dewey; Wynne Schiffer; David Schlyer; Pauline Carter; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Helene Benveniste; Paul Vaska; Nora D Volkow
Journal:  J Nucl Med       Date:  2007-09-14       Impact factor: 10.057

6.  Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims.

Authors:  N Tannu; D C Mash; S E Hemby
Journal:  Mol Psychiatry       Date:  2006-10-31       Impact factor: 15.992

7.  Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure.

Authors:  Jing Wang; Wenjing Xu; Syed F Ali; Jesus A Angulo
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice.

Authors:  Eun-Joo Shin; Duy-Khanh Dang; Hai-Quyen Tran; Yunsung Nam; Ji Hoon Jeong; Young Hun Lee; Kyung Tae Park; Yong Sup Lee; Choon-Gon Jang; Jau-Shyong Hong; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2016-09-10       Impact factor: 3.921

9.  Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure.

Authors:  Chris Derauf; Barry M Lester; Nurunisa Neyzi; Minal Kekatpure; Luis Gracia; James Davis; Kalpana Kallianpur; Jimmy T Efird; Barry Kosofsky
Journal:  Dev Neurosci       Date:  2012-08-17       Impact factor: 2.984

10.  Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.

Authors:  Despina A Tata; Bryan K Yamamoto
Journal:  Synapse       Date:  2008-05       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.